PSKH1

Serine/threonine-protein kinase H1 · P11801 · PSKH1 on Sugi Atlas →

0 patent compounds predicted against PSKH1, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to PSKH1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Salt Loading and Thiazide Intervention Study PHASE4COMPLETED
The G Protein-Coupled Receptor Kinase Type 2 Inhibitor Paroxetine as Adjunctive Therapy to Improve Insulin Sensitivity in Patients With Type 2 Diabetes Mellitus PHASE3UNKNOWN
Clinical Study of EBV-LMP1 Targeted DNAzyme to Treat Nasopharyngeal Carcinoma PHASE1/PHASE2COMPLETED
A Phase II Study of EVEROLIMUS in Patients With Primary or Relapsed Chondrosarcomas PHASE2SUSPENDED
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer PHASE1/PHASE2RECRUITING
Study of Sorafenib and Docetaxel in Metastatic Prostate Cancer PHASE2COMPLETED
NEO100 and High-Grade Meningioma PHASE2RECRUITING
Phase II Study of Neoadjuvant XELOX + Lapatinib in HER2(+) Gastric Cancer Patients With Liver Metastasis PHASE2COMPLETED
Study in Adult Ph-positive ALL PHASE2UNKNOWN
Treatment Duration Increment and Pharmacodynamic Study of CX-4945 in Patients With Basal Cell Carcinoma (BCC) PHASE1COMPLETED
Chinese Herbal Formulation PHY906 and Sorafenib Tosylate in Treating Patients With Advanced Liver Cancer PHASE1COMPLETED
FAK Inhibitor in Patients With Advanced Solid Tumors PHASE1NOT_YET_RECRUITING
Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma PHASE1COMPLETED
Intravenous Immune Globulin to Treat Hereditary Inclusion Body Myopathy PHASE1COMPLETED
Phase I Study of HeFi-1 to Treat Cancers With CD30 Protein PHASE1COMPLETED
Pre-Surgical Trial of the Combination of Metformin and Atorvastatin in Newly Diagnosed Operable Breast Cancer EARLY_PHASE1COMPLETED
Breakpoint Analysis of de Novo Apparently Balanced Chromosomal Translocations EARLY_PHASE1COMPLETED
p-AKT Expression on Clinical Outcomes in Malignant Lymphoma nanCOMPLETED
Dietary Ketosis: Fatty Acids Activate AMPK Energy Circuits Modulating Global Methylation nanCOMPLETED
Dried Fruit and Postprandial Glycemia Trial nanUNKNOWN
Biomarkers in Blood and Tissue Samples From Patients With Epstein-Barr Virus-Positive Hodgkin Lymphoma nanCOMPLETED
Genetic Variants Associated With Adolescent Suicide Attempts nanCOMPLETED
Genetic Aspects of Neurologic and Psychiatric Disorders nanCOMPLETED
Avapritinib in the Treatment of Unresectable or Recurrent Metastatic GIST Non-exon18 Mutations of PDGFRA nanRECRUITING
Abnormalities in the Effects of Insulin and Exercise on Glucose- and Lipid Metabolism in Obesity and Type 2 Diabetes nanCOMPLETED
Identification of Novel Targetable Kinases in SR-a GvHD nanCOMPLETED
Study of Proteus Syndrome and Related Congenital Disorders nanRECRUITING
Target of Suv420h1/2 in Hepatocytes nanRECRUITING
Identification of a New Blood Biomarker for the Diagnosis and Prognosis of Liposarcomas nanRECRUITING
Ischemic Preconditioning - Perspectives of Use Vivio/in Vitro Studies nanENROLLING_BY_INVITATION

Related proteins — ESM-2 sequence neighbours (a PSKH1 binder may also engage these)

ProteinNameSimilarity
Q0V7M1 1.000 Q0V7M1 →
Q91YA2 1.000 Q91YA2 →
Q501V0 1.000 Q501V0 →
Q96QS6 0.997 Q96QS6 →
Q9ZUZ2 0.996 Q9ZUZ2 →
Q66JF3 0.995 Q66JF3 →
Q4KTY1 0.994 Q4KTY1 →
O08875 0.993 O08875 →
P51138 0.993 P51138 →
Q4G050 0.993 Q4G050 →
Q2QVG8 0.993 Q2QVG8 →
PHKG2 Phosphorylase b kinase gamma catalytic chain, liver/testis isoform 0.993 landscape →
Q09137 0.993 Q09137 →
Q9DB30 0.992 Q9DB30 →
P13234 0.992 P13234 →
Q8BRK8 0.992 Q8BRK8 →
O08605 0.991 O08605 →
Q5RD00 0.991 Q5RD00 →
Q9FX86 0.991 Q9FX86 →
Q2QQR2 0.991 Q2QQR2 →
Q8VZD5 0.991 Q8VZD5 →
P11730 0.990 P11730 →
Q66I46 0.990 Q66I46 →
Q9FIM9 0.990 Q9FIM9 →
A4IGM9 0.990 A4IGM9 →
Q9SG12 0.990 Q9SG12 →
CAMK4 Calcium/calmodulin-dependent protein kinase type IV 0.990 landscape →
Q5YJC2 0.990 Q5YJC2 →
Q7XJR9 0.990 Q7XJR9 →
GSK3B Glycogen synthase kinase-3 beta 0.990 landscape →